Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Condition(s):Age-related Wet Macular DegenerationLast Updated:November 15, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Age-related Wet Macular DegenerationLast Updated:November 15, 2023Not yet recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:April 18, 2018Completed
Condition(s):Age-Related Macular DegenerationLast Updated:January 14, 2020Completed
Condition(s):Age-Related Macular DegenerationLast Updated:September 21, 2023Recruiting
Condition(s):Dry Age-related Macular DegenerationLast Updated:January 29, 2024Recruiting
Condition(s):Age-related Macular DegenerationLast Updated:December 6, 2018Completed
Condition(s):Age-Related Macular DegenerationLast Updated:July 20, 2010Completed
Condition(s):Age-Related Macular DegenerationLast Updated:April 18, 2018Completed
Condition(s):Age Related Macular DegenerationLast Updated:December 11, 2014Withdrawn
Condition(s):Age-Related Macular DegenerationLast Updated:February 7, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.